San Carlos, United States
PTM Therapeutics is a San Francisco Bay Area startup focusing on discovering and developing new therapeutics for chronic diseases and cancer. Established by a team of scientists in 2019, the company's slogan, "Targeting Post Translational Modifications for Therapeutics Development," encapsulates its mission. Rooted in the Health Care sector, PTM Therapeutics stands out in its pursuit of leveraging Post Translational Modifications (PTMs) to identify disease-specific targets for therapeutic antibodies.
The company received a significant boost with a Venture Round investment from BioRock Ventures on 01 January 2022. This strategic backing underlines the confidence of established industry players in the potential and vision of PTM Therapeutics.
With its novel approach and cutting-edge focus, PTM Therapeutics is poised to make a meaningful impact in addressing unmet medical needs. The company's commitment to leveraging PTMs to expand the scope of therapeutic targets holds promise for the development of innovative treatment options.
As the healthcare landscape continues to evolve, PTM Therapeutics appears well-positioned to drive advancements in therapeutic development and contribute to the fight against chronic diseases and cancer.
